Founded 1996 | ||
Peptech Limited used to be an Australian biotechnology company listed on the Australian Stock Exchange (ASX). Peptech described its operations as "...an ASX-listed Australian biotechnology company dedicated to developing and providing antibody and peptide-based human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals." [1] The company changed its name to Arana Therapeutics in November 2007 and was subject of a successful takeover bid by Cephalon at the end of 2009.
References
Peptech Wikipedia(Text) CC BY-SA